Merck & Co., Inc. (MRK) stock
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30106% above fair value
$146.95−0.23 (-0.16%)
Close on Nov 12, 2026Market cap $362.55BP/E 151.5Yield 2.23%
Merck profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Merck's profit margin for the twelve months ending Sep 30, 2026 was 3.6%. For fiscal 2025 it was 28.1%, against 26.7% the year before. The highest annual figure on record is 47.0% in fiscal 2009.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.1% | +1.4 |
| FY2024 | Dec 31, 2024 | 26.7% | +26.1 |
| FY2023 | Dec 31, 2023 | 0.6% | −23.9 |
| FY2022 | Dec 31, 2022 | 24.5% | −2.3 |
| FY2021 | Dec 31, 2021 | 26.8% | +9.8 |
| FY2020 | Dec 31, 2020 | 17.0% | −8.1 |
| FY2019 | Dec 31, 2019 | 25.2% | +10.5 |
| FY2018 | Dec 31, 2018 | 14.7% | +8.7 |
| FY2017 | Dec 31, 2017 | 6.0% | −3.9 |
| FY2016 | Dec 31, 2016 | 9.8% | −1.4 |
| FY2015 | Dec 31, 2015 | 11.2% | −17.0 |
| FY2014 | Dec 31, 2014 | 28.2% | +18.2 |
| FY2013 | Dec 31, 2013 | 10.0% | −3.0 |
| FY2012 | Dec 31, 2012 | 13.0% | −0.0 |
| FY2011 | Dec 31, 2011 | 13.1% | +11.2 |
| FY2010 | Dec 31, 2010 | 1.9% | −45.2 |
| FY2009 | Dec 31, 2009 | 47.0% | +14.3 |
| FY2008 | Dec 31, 2008 | 32.7% | +19.2 |
| FY2007 | Dec 31, 2007 | 13.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 28.0% | −5.5 |
| Q2 FY2026 | Jun 30, 2026 | -8.0% | −36.0 |
| Q1 FY2026 | Mar 31, 2026 | -26.0% | −58.7 |
| Q4 FY2025 | Dec 31, 2025 | 18.1% | −5.9 |
| Q3 FY2025 | Sep 30, 2025 | 33.5% | +14.5 |
| Q2 FY2025 | Jun 30, 2025 | 28.0% | −5.8 |
| Q1 FY2025 | Mar 31, 2025 | 32.7% | +2.5 |
| Q4 FY2024 | Dec 31, 2024 | 24.0% | +32.3 |
| Q3 FY2024 | Sep 30, 2024 | 19.0% | −10.8 |
| Q2 FY2024 | Jun 30, 2024 | 33.9% | +73.6 |
| Q1 FY2024 | Mar 31, 2024 | 30.2% | +10.7 |
| Q4 FY2023 | Dec 31, 2023 | -8.4% | −30.2 |
| Q3 FY2023 | Sep 30, 2023 | 29.7% | +8.0 |
| Q2 FY2023 | Jun 30, 2023 | -39.7% | −66.8 |
| Q1 FY2023 | Mar 31, 2023 | 19.5% | −7.6 |
| Q4 FY2022 | Dec 31, 2022 | 21.8% | −6.0 |
| Q3 FY2022 | Sep 30, 2022 | 21.7% | −13.0 |
| Q2 FY2022 | Jun 30, 2022 | 27.0% | +13.5 |
| Q1 FY2022 | Mar 31, 2022 | 27.1% | −2.8 |
| Q4 FY2021 | Dec 31, 2021 | 27.8% | +46.9 |
| Q3 FY2021 | Sep 30, 2021 | 34.7% | +7.8 |
| Q2 FY2021 | Jun 30, 2021 | 13.6% | −18.5 |
| Q1 FY2021 | Mar 31, 2021 | 29.9% | +3.2 |
| Q4 FY2020 | Dec 31, 2020 | -19.1% | −75.9 |
| Q3 FY2020 | Sep 30, 2020 | 26.9% | +11.6 |
| Q2 FY2020 | Jun 30, 2020 | 32.1% | +9.4 |
| Q1 FY2020 | Mar 31, 2020 | 26.7% | −0.3 |
| Q4 FY2019 | Dec 31, 2019 | 56.8% | +40.2 |
| Q3 FY2019 | Sep 30, 2019 | 15.3% | −2.7 |
| Q2 FY2019 | Jun 30, 2019 | 22.7% | +6.4 |
| Q1 FY2019 | Mar 31, 2019 | 27.0% | +19.6 |
| Q4 FY2018 | Dec 31, 2018 | 16.6% | +26.6 |
| Q3 FY2018 | Sep 30, 2018 | 18.1% | +18.6 |
| Q2 FY2018 | Jun 30, 2018 | 16.3% | −3.3 |
| Q1 FY2018 | Mar 31, 2018 | 7.3% | −9.1 |
| Q4 FY2017 | Dec 31, 2017 | -10.0% | −4.1 |
| Q3 FY2017 | Sep 30, 2017 | -0.5% | – |
| Q2 FY2017 | Jun 30, 2017 | 19.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 16.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -5.9% | – |
See a number that looks wrong?